HeartMate 3
Device
Abbott Laboratories
Total Payments
$1.9M
Transactions
855
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $1.9M | 831 | 0 |
| 2019 | $3,558 | 24 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.9M | 831 | 99.8% |
| Travel and Lodging | $2,475 | 10 | 0.1% |
| Food and Beverage | $1,083 | 14 | 0.1% |
Payments by Type
Research
$1.9M
831 transactions
General
$3,558
24 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MOMENTUM 3 CAP Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3 Continued Access Protocol | Abbott Laboratories | $1.3M | 0 |
| Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow Percutaneous Left Ventricular Support Device (SHIELD II) | Abbott Laboratories | $538,474 | 0 |
| Thoratec Corporation MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3 IDE Clinical Study Protocol | Abbott Laboratories | $26,498 | 0 |
| Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical Techniques Other Than Full Median Sternotomy | Abbott Laboratories | $3,187 | 0 |
Top Doctors Receiving Payments for HeartMate 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Durham, NC | $1.9M | 831 |
| , M.D | Advanced Heart Failure and Transplant Cardiology | Cleveland, OH | $1,889 | 10 |
| , D.O. PH.D | Internal Medicine | Miami, FL | $1,669 | 14 |
Ad
Manufacturing Companies
- Abbott Laboratories $1.9M
Product Information
- Type Device
- Total Payments $1.9M
- Total Doctors 2
- Transactions 855
About HeartMate 3
HeartMate 3 is a device associated with $1.9M in payments to 2 healthcare providers, recorded across 855 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2020. In 2020, $1.9M was paid across 831 transactions to 0 doctors.
The most common payment nature for HeartMate 3 is "Unspecified" ($1.9M, 99.8% of total).
HeartMate 3 is associated with 4 research studies, including "MOMENTUM 3 CAP Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3 Continued Access Protocol" ($1.3M).